Category: illness
Johnson & Johnson’s COVID-19 vaccine is 85% effective against severe cases, and 66% effective overall per trial data
Another COVID-19 vaccine is almost ready to begin being distributed – a single-shot inoculation made by Johnson & Johnson’s Janssen pharmaceutical subsidiary. The company just released an efficacy report based on data from its Phase 3 trial, which found that the new vaccine is 66% effective overall in preventing moderate…
Read More
Lucid Lane has developed a service to get patients off of pain meds and avoid addiction
Four years ago, Adnan Asar, the founder of the new addiction prevention service Lucid Lane, was enjoying a successful career working as the founding chief technology officer at Livongo Health. It was the serial senior tech executive’s most recent job after a long stint at Shutterfly and he was shepherding…
Read More
NWU researchers develop a throat-worn wearable that could offer early warnings for COVID-19 patients
The ongoing COVID-19 pandemic is resulting in big shifts across industries, but the development of more long-term solutions that address a future in which what we need to do is mitigate the impact of the new coronavirus seems like a worthwhile place to invest time and effort. Projects like a…
Read More
Stanford, Scripps and Fitbit try using wearables to detect infections
The smartwatch on your wrist might one day be key to containing the spread of viruses like the one behind COVID-19. Stanford, Scripps Research and Fitbit have unveiled an initiative that, if successful, would use wearables to catch the early signs of… Source
Read More
Non-profit launches COVID-19 treatment and vaccine tracker with daily updates
There are a lot of global efforts underway to develop vaccines and treatments for COVID-19, including repurposing of existing drugs approved for use in treating other forms of coronavirus and respiratory diseases. Many of these efforts are just entering into the formal clinical study phase, which will be required before…
Read More
Nvidia makes its GPU-powered genome sequencing tool available free to those studying COVID-19
Nvidia is making its Parabricks tool available for free for 90 days (with the possibility of extension, depending on needs) to any researcher currently working on any effort to combat the ongoing novel coronavirus pandemic and spread of COVID-19. The tool is a GPU-accelerated genome analysis toolkit, which leveraged graphics…
Read More